Keep up to date with our latest news on brain tumours, including charity updates, blog posts and research developments
13 Sept. 2019
Tocagen, an American gene-therapy company, announced the trial’s failure yesterday.
09 Sept. 2019
For a limited time the voting is open to decide the semifinalists in our Brain Race, with the Centre for Advancing Innovation. Which discoveries do you want to see go ...
27 Aug. 2019
New findings out of the University of Sussex could be paving the way to a new test for glioblastoma (GBM) using only fluids, like blood or cerebrospinal fluid.
10 Aug. 2019
Researchers at The University of California, San Diego, have found that a drug called teriflunomide has the ability to boost the effectiveness of chemotherapy drugs to treat glioblastomas.
01 Aug. 2019
Dr Martina Finetti tells us about her background and her research into rare childhood brain tumours.
24 July 2019
Researchers at St. Jude Children’s Hospital uncover the origins of medulloblastoma subgroup using single cell sequencing.
18 July 2019
Our Research Communications & Engagement Officer, Arshiya, shares some of the most exciting highlight from the 2019 annual British Neuro-Oncology Society (BNOS) conference.
09 July 2019
We have recently announced we will funding a study that looks at whether a therapy called Acceptance and Commitment Therapy (ACT) can be adapted to help treat young brain tumour ...
08 July 2019
With funding from The Brain Tumour Charity, researchers in Toronto, Canada are using the power of artificial intelligence (AI) to improve brain tumour diagnosis
26 June 2019
We’re delighted to announce our £1.35m investment in a pioneering drive to help accelerate research into brain tumours at one of the UK’s leading universities.
25 June 2019
Our Research Communications & Engagement Officer, Arshiya, shares some of the most exciting results from the American Society of Clinical Oncology (ASCO) conference
17 June 2019
Our funded research has created a tool to help clinicians predict meningioma recurrence
17 June 2019
Scottish scientist set to receive over £6 million from Cancer Research UK and The Brain Tumour Charity to find new ways to treat glioblastoma, one of the hardest types of ...
13 June 2019
Thanks to the support of our community, we’re pledging more than £3.7m to UK and international teams working towards our twin goals: doubling brain tumour survival and halving the harm ...
28 May 2019
After undergoing an interim analysis, a phase 3 clinical trial called Toca 5 that tests a gene therapy in patients with recurrent brain cancer, will continue
21 May 2019
Deputax-M failed to meet its target overall survival during an interim analysis of a phase 3 clinical trial in glioblastoma
16 May 2019
Nivolumab, an immunotherapy drug, has been unsuccessful in improving overall survival in a phase 3 clinical trial when tested in newly diagnosed glioblastoma with unmethylated MGMT
15 May 2019
New research from one of our funded grants gives much needed insight into group 3 and 4 medulloblastoma